Singapore - English - HSA (Health Sciences Authority)

singapore radiopharmaceuticals pte. ltd. - sodium fluoride f18 - injection, solution (radiopharmaceutical) - 10-200mci/ml - sodium fluoride f18 10-200mci/ml

European Union - English - EMA (European Medicines Agency)

ge healthcare as - flutemetamol (18f) - radionuclide imaging; alzheimer disease - diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only.vizamyl is a radiopharmaceutical medicinal product indicated for positron emission tomography (pet) imaging of β amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for alzheimer’s disease (ad) and other causes of cognitive impairment. vizamyl should be used in conjunction with a clinical evaluation.a negative scan indicates sparse or no plaques, which is not consistent with a diagnosis of ad.

United States - English - NLM (National Library of Medicine)

jubilant draximage inc., dba jubilant radiopharma - pentetic acid (unii: 7a314hqm0i) (pentetic acid - unii:7a314hqm0i) - pentetic acid 20 mg - draximage® dtpa, after radiolabeling with technetium tc 99m, is indicated for brain imaging in adults by intravenous administration. renal visualization, assessment of renal perfusion, and estimation of glomerular filtration rate in adult and pediatric patients by intravenous administration. lung ventilation imaging and evaluation of pulmonary embolism when paired with perfusion imaging in adult and pediatric patients when administered by nebulizer for inhalation. hypersensitivity to the active ingredient or to any component of the product [see warnings and precautions (5.1)]. risk summary limited available data with technetium tc 99m pentetate use in pregnant women are insufficient to inform a drug associated risk for major birth defects and miscarriage. technetium tc 99m pentetate is transferred across the placenta (see data) . no animal reproductive studies have been conducted with technetium tc 99m pentetate. all radiopharmaceuticals have the potential to cause fetal harm depending on the fetal stage of

Australia - English - Department of Health (Therapeutic Goods Administration)

landauer radiopharmaceuticals pty ltd - tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate, quantity: 1 mg - injection, powder for - excipient ingredients: stannous chloride dihydrate; cysteine hydrochloride monohydrate; sodium citrate dihydrate; mannitol; hydrochloric acid; sodium hydroxide - technetium [99m tc] sestamibi is indicated for use in conjunction with stress testing as an adjunct in the diagnosis of ischaemic heart disease. in these patients additional information about ventricular function may be derived by using the first pass technique. technetium [99m tc] sestamibi is indicated as a second line diagnostic aid to assist in the evaluation of patients for whom mammography is inconclusive.

United States - English - NLM (National Library of Medicine)

ucsf radiopharmaceutical facility - fludeoxyglucose f-18 (unii: 0z5b2cjx4d) (fludeoxyglucose f-18 - unii:0z5b2cjx4d) - fludeoxyglucose f-18 300 mci in 1 ml - fludeoxyglucose f 18 injection ​ is indicated for positron emission tomography (pet) imaging in the following settings: for assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging. for the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures. none. risk summary data from published case series and case reports describe fludeoxyglucose f 18 injection crossing the placenta with uptake by the fetus (see data). all radiopharmaceuticals have the potential to cause fetal harm depending on the fetal stage of development and the magnit

Australia - English - Department of Health (Therapeutic Goods Administration)

landauer radiopharmaceuticals pty ltd - indium (111in) chloride,pentetreotide -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

norgine pharmaceuticals ltd - kit for radiopharmaceutical preparation

Australia - English - Department of Health (Therapeutic Goods Administration)

landauer radiopharmaceuticals pty ltd - sodium oxidronate, quantity: 3.15 mg - injection, powder for - excipient ingredients: sodium chloride; gentisic acid; stannous chloride dihydrate - technescan hdp is a diagnostic skeletal imaging agent used to demonstrate areas of altered osteogenesis in patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

landauer radiopharmaceuticals pty ltd - stannous chloride dihydrate, quantity: 19.2 microgram/ml - injection, powder for - excipient ingredients: sodium citrate dihydrate; glucose - technetium tc99m- labelled red blood cells are used for cardiac first pass & gated equilibrium imaging

Australia - English - Department of Health (Therapeutic Goods Administration)

landauer radiopharmaceuticals pty ltd - betiatide, quantity: 1 mg - injection, powder for - excipient ingredients: stannous chloride dihydrate; sodium tartrate dihydrate; lactose monohydrate - for use in the preparation of technetium tc99m mertiatide for use as a renal imaging agent and for estimating split renal function. indications as at 19 july 2001: technetium tc 99m mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients. (see pediatric use.) it is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex.